Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 242
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
18 and over
Pharmaceutical / Industry
08-0106
NCT00748085
2.
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care, Treatment
Active
18 and over
Other
001-0015-211
NCT00127387
3.
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 to 85
Other
20050113
NCT00243685
Last Modified:
10/8/2008
 
First Published:
10/25/2004
4.
Phase III Randomized Study of Whole Brain Radiotherapy and Stereotactic Radiosurgery With Versus Without Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and Brain Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
RTOG-0320
RTOG-0320, NCT00096265
5.
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
CP02-0452
NCT00095199
Last Modified:
6/12/2008
 
First Published:
7/7/2006
6.
Phase III Randomized Study of a Botanical Dietary Supplement (Selected Vegetables and Herbs Mix [SV]) in Patients Who are Receiving Chemotherapy For Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
SFC-SV001
SFC-01-0150-0001-02-CM, SFC-01-0150-001, NCT00246727
7.
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
NOV002-C301
NCT00347412
Last Modified:
10/9/2008
 
First Published:
9/10/2006
8.
Phase III Randomized Study of Stereotactic Radiosurgery With Versus Without Whole-Brain Radiotherapy in Patients With Cerebral Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
NCCTG-N0574
N0574, ACOSOG-N0574, NCT00377156
9.
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
HYT105962
NCT00390806
10.
A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
CBA-TP0301
NCT00437749
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute